These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25312269)
1. Common genetic variants in NEFL influence gene expression and neuroblastoma risk. Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269 [TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812 [TBL] [Abstract][Full Text] [Related]
3. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701 [TBL] [Abstract][Full Text] [Related]
4. Association between Wu Q; Zhuo ZJ; Zeng J; Zhang J; Zhu J; Zou Y; Zhang R; Yang T; Zhu D; He J; Xia H J Cancer; 2018; 9(3):535-539. PubMed ID: 29483959 [TBL] [Abstract][Full Text] [Related]
5. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor. Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831 [TBL] [Abstract][Full Text] [Related]
6. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Diskin SJ; Capasso M; Schnepp RW; Cole KA; Attiyeh EF; Hou C; Diamond M; Carpenter EL; Winter C; Lee H; Jagannathan J; Latorre V; Iolascon A; Hakonarson H; Devoto M; Maris JM Nat Genet; 2012 Oct; 44(10):1126-30. PubMed ID: 22941191 [TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027 [TBL] [Abstract][Full Text] [Related]
8. Association of Jia W; Zhu J; Fu W; Zhu S; Deng F; Xia H; Liu GC; He J J Oncol; 2019; 2019():3518149. PubMed ID: 31057612 [TBL] [Abstract][Full Text] [Related]
9. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317 [TBL] [Abstract][Full Text] [Related]
10. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175 [TBL] [Abstract][Full Text] [Related]
11. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895 [TBL] [Abstract][Full Text] [Related]
12. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Russell MR; Penikis A; Oldridge DA; Alvarez-Dominguez JR; McDaniel L; Diamond M; Padovan O; Raman P; Li Y; Wei JS; Zhang S; Gnanchandran J; Seeger R; Asgharzadeh S; Khan J; Diskin SJ; Maris JM; Cole KA Cancer Res; 2015 Aug; 75(15):3155-66. PubMed ID: 26100672 [TBL] [Abstract][Full Text] [Related]
13. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1. Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754 [TBL] [Abstract][Full Text] [Related]
14. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156 [TBL] [Abstract][Full Text] [Related]
15. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409 [TBL] [Abstract][Full Text] [Related]
16. [Colorectal cancer susceptibility genetic variants in tumor free and colorectal carcinoma bearing Hungarian population. Individual predisposition to cancer]. Szentirmay Z; Kurcsics J; Csernák E; Tándor I; Tóth E Orv Hetil; 2018 Oct; 159(40):1614-1623. PubMed ID: 30277414 [TBL] [Abstract][Full Text] [Related]
17. Allele-specific transcription factor binding to common and rare variants associated with disease and gene expression. Cavalli M; Pan G; Nord H; Wallerman O; Wallén Arzt E; Berggren O; Elvers I; Eloranta ML; Rönnblom L; Lindblad Toh K; Wadelius C Hum Genet; 2016 May; 135(5):485-497. PubMed ID: 26993500 [TBL] [Abstract][Full Text] [Related]
18. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population. He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839 [TBL] [Abstract][Full Text] [Related]
19. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population. Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572 [TBL] [Abstract][Full Text] [Related]
20. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies. Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]